The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000567325
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
7/04/2026
Date registered
Help: Date registered
5/05/2026
Date last updated
Help: Date last updated
5/05/2026
Date data sharing statement initially provided
Help: Data sharing statement date
5/05/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Pilot Nicotine Cessation Intervention for Adolescent Young Adults (18-24 years) in South Australia
Scientific title
Recruitment and Preference of Pilot Nicotine Cessation Intervention for Adolescent Young Adults (18-24 years) in South Australia
Additional trial identifiers [1] 316793 0
Nil known
Universal Trial Number (UTN)
Trial acronym
QuitNic
Related trial records

Health condition
Health condition(s) studied:
Nicotine use 341127 0
Condition category
Condition code
Respiratory 337236 337236 0 0
Other respiratory disorders / diseases
Mental Health 337656 337656 0 0
Addiction

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Participants will self-select in one of the 4 available interventions for a 4-week intervention period:

Quitline referral: An online Quitline referral will be made by study staff on behalf of the participant. Quitline will then contact the participant to schedule their first phone counselling session. Participants may engage with Quitline as many times as desired, with phone calls typically lasting between 5-20mins, Quitline counsellors may provide support for quitting through various strategies, including education for craving management, goal-setting and tailoring a quit-plan to the caller's needs. Participants will self-report the number of Quitline sessions in which they participated at their 4-week follow-up.

Financial incentives: 2-weeks post study enrolment, a survey will be digitally sent to participants in this arm, requiring them to self-report their nicotine abstinence status. If they report abstinence, they will be required to biochemically verify with a saliva cotinine test; participants will choose for the test to either be posted and completed over video call with researchers, or completed in-person with researchers at the designated University campus. If the test verifies their abstinence, they will receive a $30 supermarket voucher. If they report that they are still using nicotine, or the test does not verify abstinence, they will not receive a voucher. At the 4-week follow-up, participants will receive $50 for verified abstinence and completing the survey, otherwise will receive $20 for completing the follow-up survey (in-line with other intervention arms) without achieving abstinence.

Text-based counselling: Participants will interact with the designated number and enroll with the text-based cessation support program which features interactive and automated, tailored texts. Texts will be sent over a 4-week period and will be tailored to the participant's chosen quit-date. Texts will be sent an average of 3 times per week, and will vary in content depending on proximity to quit-date eg texts sent pre-quit date will provide motivational content and goal-setting, texts sent soon after quit-date will be focused on craving management strategies and reminders of goals, texts sent weeks after quit-date will celebrate quit success and maintenance of abstinence. Participants also have the option to send keywords to receive support for specific needs eg cravings, motivation etc, and may reset their quit-date at any stage.

Self-directed quitting: Participants are instructed to undergo a self-directed quit attempt for the duration of the study that does not use any of the included interventions. Participants may seek any form of quit-support that is not included within the 3 intervention arms.

15-20 participants will be recruited for post-intervention interviews. The 4-week follow-up survey will include an opt-in selection for interviews; the first 20 participants to opt-in will be included. If recruitment does not reach minimum requirements through this method, researchers will contact participants directly to complete recruitment.
Intervention code [1] 333487 0
Behaviour
Description of the comparator or control
This study does not have a single designated comparator arm, but rather 4 intervention arms which act as active comparators. Each intervention will be compared to each other within analysis.
Control group
Active

Outcomes
Primary outcome [1] 344767 0
Recruitment numbers per recruitment strategy
Timepoint [1] 344767 0
End of recruitment window (3-months)
Primary outcome [2] 344889 0
Intervention preference (Primary outcome 2A)
Timepoint [2] 344889 0
- End of recruitment phase (3-months)
Secondary outcome [1] 459617 0
Feasibility of recruitment strategies (pre-intervention) (secondary outcome 1A)
Timepoint [1] 459617 0
- End of recruitment window (3-months)
Secondary outcome [2] 459618 0
Intervention engagement (during intervention) (secondary outcome 2A)
Timepoint [2] 459618 0
- 4-week follow-up survey
Secondary outcome [3] 459619 0
Participant retention (secondary outcome 3A)
Timepoint [3] 459619 0
- End of study (4-months)
Secondary outcome [4] 459620 0
7-day point prevalence abstinence (secondary outcome 4A)
Timepoint [4] 459620 0
- 2-weeks (for text-based counselling arm) - 4 -weeks (for participants reporting abstinence in 4-week follow-up survey)
Secondary outcome [5] 459621 0
30-day continuous abstinence (secondary outcome 5A)
Timepoint [5] 459621 0
-4-week follow-up survey
Secondary outcome [6] 459622 0
Perception of recruitment strategy effectiveness
Timepoint [6] 459622 0
Baseline survey
Secondary outcome [7] 459624 0
Quitting history
Timepoint [7] 459624 0
- Baseline survey - 4-week follow-up survey
Secondary outcome [8] 459625 0
Change in perceived usefulness of intervention in supporting to quit
Timepoint [8] 459625 0
- Baseline survey - 4-week follow-up survey
Secondary outcome [9] 459626 0
Change in motivation to quit/stay quit
Timepoint [9] 459626 0
- Baseline survey - 4-week follow-up survey
Secondary outcome [10] 459627 0
Change in confidence to quit/stay quit
Timepoint [10] 459627 0
Baseline survey 4-week follow-up survey
Secondary outcome [11] 459628 0
Change in self-reported knowledge of consequences
Timepoint [11] 459628 0
- Baseline survey - 4-week survey
Secondary outcome [12] 459629 0
Change in self-reported knowledge of available supports
Timepoint [12] 459629 0
- Baseline survey - 4-week follow-up survey
Secondary outcome [13] 459630 0
Change in self-reported knowledge of craving management
Timepoint [13] 459630 0
- Baseline survey - 4-week follow-up survey
Secondary outcome [14] 459631 0
Satisfaction with intervention
Timepoint [14] 459631 0
- Baseline survey - 4-week follow-up survey
Secondary outcome [15] 459632 0
Change in perceived addictedness to nicotine
Timepoint [15] 459632 0
- Baseline survey - 4-week follow-up survey
Secondary outcome [16] 459633 0
Perceived appropriateness of AI in support tools
Timepoint [16] 459633 0
4-week follow-up survey
Secondary outcome [17] 459634 0
Change in perception of importance of varied elements of quit interventions
Timepoint [17] 459634 0
- Baseline survey - 4-week follow-up survey
Secondary outcome [18] 460932 0
Intervention preference (primary outcome 2B)
Timepoint [18] 460932 0
-Baseline survey - 4-week follow-up survey
Secondary outcome [19] 460933 0
Intervention preference (primary outcome 2C)
Timepoint [19] 460933 0
Post-intervention interviews.
Secondary outcome [20] 460934 0
Feasibility of recruitment strategies (pre-intervention) (secondary outcome 1B)
Timepoint [20] 460934 0
End of recruitment window (3-months)
Secondary outcome [21] 460935 0
Feasibility of recruitment strategies (pre-intervention) (secondary outcome 1)C
Timepoint [21] 460935 0
End of recruitment window (3-months)
Secondary outcome [22] 460936 0
Feasibility of recruitment strategies (pre-intervention) (secondary outcome 1D)
Timepoint [22] 460936 0
- End of recruitment window (3-months)
Secondary outcome [23] 460937 0
Feasibility of recruitment strategies (pre-intervention) (secondary outcome 1E)
Timepoint [23] 460937 0
- Post-intervention interviews
Secondary outcome [24] 460938 0
Intervention engagement (during intervention) (secondary outcome 2B)
Timepoint [24] 460938 0
- End of study (4-months)
Secondary outcome [25] 460939 0
Intervention engagement (during intervention) (secondary outcome 2C)
Timepoint [25] 460939 0
- 4-week follow-up survey
Secondary outcome [26] 460940 0
Participant retention (secondary outcome 3B)
Timepoint [26] 460940 0
Post-intervention interviews
Secondary outcome [27] 460941 0
7-day point prevalence abstinence (secondary outcome 4B)
Timepoint [27] 460941 0
- 2-week abstinence check-in survey for text-based counselling arm - 4-week follow-up survey for all participants
Secondary outcome [28] 460942 0
7-day point prevalence abstinence (secondary outcome 4C)
Timepoint [28] 460942 0
Post-intervention interviews
Secondary outcome [29] 460943 0
30-day continuous abstinence (secondary outcome 5B)
Timepoint [29] 460943 0
Post-intervention interviews

Eligibility
Key inclusion criteria
• Age: 18-24 years old
• Geographic location: Currently living in South Australia
• Nicotine use status: Current regular user of nicotine, including but not limited to the following products: e-cigarettes, cigarettes, nicotine pouches, snus, snuff, hookah. ‘Regular user’ will be defined as 1 use in past 30-days.
• Willing to make a quit attempt during the study duration
Minimum age
18 Years
Maximum age
24 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
• Cannot read, write or speak in English
• Located outside of South Australia
• Fails to provide consent
• Reports being currently unwilling to make a quit attempt
• Relevant only to post-intervention interviews: withdrawn from nicotine cessation pilot study

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
SA

Funding & Sponsors
Funding source category [1] 321388 0
University
Name [1] 321388 0
Adelaide University - PhD scholarship
Country [1] 321388 0
Australia
Primary sponsor type
Other
Name
Houd Research Group - Project funding
Address
Country
Australia
Secondary sponsor category [1] 324132 0
None
Name [1] 324132 0
Address [1] 324132 0
Country [1] 324132 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319929 0
University of Adelaide Human Research Ethics Committee
Ethics committee address [1] 319929 0
Ethics committee country [1] 319929 0
Australia
Date submitted for ethics approval [1] 319929 0
05/02/2026
Approval date [1] 319929 0
24/02/2026
Ethics approval number [1] 319929 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 148854 0
Miss Tahlia Grammatopoulos
Address 148854 0
College of Health Adelaide University Adelaide Health and Medical Sciences building Corner of North Terrace & George Street Adelaide, SA 5000
Country 148854 0
Australia
Phone 148854 0
+61 8 8313 8163
Fax 148854 0
Email 148854 0
Contact person for public queries
Name 148855 0
Tahlia Grammatopoulos
Address 148855 0
College of Health Adelaide University Adelaide Health and Medical Sciences building Corner of North Terrace & George Street Adelaide, SA 5000
Country 148855 0
Australia
Phone 148855 0
+61 8 8313 8163
Fax 148855 0
Email 148855 0
Contact person for scientific queries
Name 148856 0
Tahlia Grammatopoulos
Address 148856 0
College of Health Adelaide University Adelaide Health and Medical Sciences building Corner of North Terrace & George Street Adelaide, SA 5000
Country 148856 0
Australia
Phone 148856 0
+61 8 8313 8163
Fax 148856 0
Email 148856 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: It is detailed within the ethics approval for this project that data may only be shared with members of the research team.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.